DAPTS ACE
- Conditions
- intracranial aneurysm
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
1 stent assisted embolization of intracranial aneurysm
2 receive aspirin and clopidogrel
3 Provided written informed consent within 30 days after embolization of intracranial aneurysm
4 20 year old or more
5 document informed consent
1 previous history of stent assisted embolization for target intracranial aneurysms in the past
2 withdraw anti platelet treatment is scheduled during study
3 acute ruptured (within 14 days)
4 history of allergy for aspirin or clopidogrel
5 inappropriate for withdraw DAPT at 3 months
6 baseline platelet count less than 100,000/mm3
7 need anti-coagulant treatment
8 intracranial hemorrhage or hemorrhagic tendency
9 any clinical evidence indicating the increase in bleeding risk by the investigators
10 inadequate for the study enrollment by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method - ischemic stroke during 3 to 12 months after stent assisted embolization of intracranial aneurysm
- Secondary Outcome Measures
Name Time Method death and all stroke 3 to 12 months after stent assisted embolization death and all stroke during 3 to 12 months after stent assisted embolization of intracranial aneurysm
hemorrhagic event 3 to 12 months after stent assisted embolization hemorrhagic event during 3 to 12 months after stent assisted embolization of intracranial aneurysm
death, stake and hemorrhagic event 3 to 12 months after stent assisted embolization death, stake and hemorrhagic event during 3 to 12 months after stent assisted embolization of intracranial aneurysm
pretreatment and stenosis or occlusion go stent 3 to 12 months after stent assisted embolization pretreatment and stenosis or occlusion go stent during 3 to 12 months after stent assisted embolization of intracranial aneurysm